Committed to a polio-free India
Every 2nd child in India receives Sanofi Pasteur’s Inactivated Polio Vaccine (IPV).
Fighting rare diseases together
Addressing the challenges faced by patients with rare diseases.
Sheer grit in the face of adversity
“Type 1 diabetes doesn’t mean the end of the world,” - Eshaan Shevate.
Why join Sanofi?
Shantha Biotechnics’ Inactivated Polio Vaccine – ShanIPV™ prequalified by the World Health Organization (WHO)
Our Inactivated Polio Vaccine - ShanIPV™ received prequalification status from the World Health Organization (WHO). This status qualifies ShanIPV™ vaccine for purchase by the United Nations’ agencies.
Combiflam® Range of Pain Relief Solutions introduces Pain Education Campaign in Bihar
Pain clinics comprises a series of doctor and pain expert videos that educate people to treat pain in an informed and responsible manner.
2018-10-10MMMM DD YYYY
Sanofi launches ‘Aubagio®’ for treatment of Multiple Sclerosis in India
Offers patients diagnosed with Multiple Sclerosis the efficacy and convenience of once-a-day oral treatment.
Contact for medical information or pharmacovigilanceFor reporting adverse events: PV.email@example.com
For medical information (healthcare professionals only): firstname.lastname@example.org
All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.
Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide. A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.
You can email or call us between 9AM and 5PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 1 for medical information and IVRS option 3 for reporting adverse events.